Phase I study of the antiprogrammed cell death-1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies.
Minami H, Doi T, Toyoda M, Imamura Y, Kiyota N, Mitsuma A, Shimokata T, Naito Y, Matsubara N, Tajima T, Tokushige K, Ishihara K, Cameron S, Ando Y.
Minami H, et al. Among authors: tokushige k.
Cancer Sci. 2021 Feb;112(2):725-733. doi: 10.1111/cas.14678. Epub 2020 Dec 22.
Cancer Sci. 2021.
PMID: 33031626
Free PMC article.
Clinical Trial.